Abandoned reports: National Assembly’s long list of endless probes, loud hearings, dead results The Punch
Published 10 May 2021
SUNDAY ABORISADE and
LEKE BAIYEWU examine endless probes by both chambers of the National Assembly and observe that the investigations have produced few or no effects
Consecutively, Speaker of the House of Representatives, Femi Gbajabiamila, asked all ad hoc committees of the House to lay their reports by the end of April 2021. He made the announcement on April 20; reminded the concerned committees again on April 21.
Indeed, many probes have been pending – or even abandoned – by the various panels given the tasks. Yet, hardly does the House sit without resolving to carry out one investigation or the other. It is a similar case in the Senate.
Punch Newspapers
Sections
SUNDAY ABORISADE and LEKE BAIYEWU
Published 10 May 2021
Published 10 May 2021
SUNDAY ABORISADE and
LEKE BAIYEWU examine endless probes by both chambers of the National Assembly and observe that the investigations have produced few or no effects
Consecutively, Speaker of the House of Representatives, Femi Gbajabiamila, asked all ad hoc committees of the House to lay their reports by the end of April 2021. He made the announcement on April 20; reminded the concerned committees again on April 21.
Indeed, many probes have been pending – or even abandoned – by the various panels given the tasks. Yet, hardly does the House sit without resolving to carry out one investigation or the other. It is a similar case in the Senate.
COVID-19 vaccine: NAFDAC rules out clinical trial
• Reps set to revisit bill mandating vaccines for Nigerians
• FG places six-month ban on 100 travellers for shunning PCR test
• Bayelsa, Ebonyi postpone school resumption, Rivers resumes Monday
Our Reporters
The National Agency for Food and Drug Administration and Control has ruled out the possibility of conducting a local clinical trial on the proposed N400bn vaccines before administering them on Nigerians.
The agency said since the World Health Organisation had approved the vaccines there might not be need to conduct another clinical trial on the vaccines.
It, however, said it would subject vaccines, which the Federal Government may likely spend N400bn to procure, to proper revalidation before administering them on Nigerians.